Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.760 BRL | -0.59% |
|
-0.29% | -25.96% |
Company Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 747.9 | 723.4 | 450 | 747.9 | 795.7 | 1,119 |
| Change | - | -3.28% | -37.8% | 66.21% | 6.39% | 40.68% |
| Enterprise Value (EV) 1 | 1,277 | 1,482 | 1,291 | 1,698 | 1,813 | 2,286 |
| Change | - | 16.05% | -12.88% | 31.53% | 6.77% | 26.1% |
| P/E | 14.3x | 9.25x | 5.56x | 10.6x | 6.95x | 9.42x |
| PBR | 0.71x | 0.67x | 0.38x | 0.6x | 0.61x | 0.83x |
| PEG | - | 0.2x | 1.62x | -0.8x | 0.1x | 2.46x |
| Capitalization / Revenue | 0.14x | 0.11x | 0.06x | 0.09x | 0.08x | 0.1x |
| EV / Revenue | 0.23x | 0.23x | 0.17x | 0.2x | 0.18x | 0.2x |
| EV / EBITDA | 8.52x | 9.11x | 4.54x | 5.74x | 5.3x | 5.65x |
| EV / EBIT | 9.95x | 10.9x | 5.09x | 6.5x | 6.05x | 6.53x |
| EV / FCF | -50.4x | -136x | -22.6x | -101x | 11.3x | 34.7x |
| FCF Yield | -1.98% | -0.73% | -4.42% | -0.99% | 8.82% | 2.88% |
| Dividend per Share 2 | - | 0.2706 | 0.1733 | 0.3858 | 0.575 | - |
| Rate of return | - | 4.59% | 4.72% | 6.32% | 8.86% | - |
| EPS 2 | 0.4268 | 0.6377 | 0.6596 | 0.574 | 0.934 | 0.9697 |
| Distribution rate | - | 42.4% | 26.3% | 67.2% | 61.6% | - |
| Net sales 1 | 5,481 | 6,413 | 7,816 | 8,662 | 10,154 | 11,451 |
| EBITDA 1 | 149.9 | 162.7 | 284.2 | 295.6 | 342.1 | 404.5 |
| EBIT 1 | 128.3 | 136.3 | 253.8 | 261.1 | 299.7 | 350.1 |
| Net income 1 | 52.33 | 78.19 | 80.87 | 70.4 | 114.6 | 118.9 |
| Net Debt 1 | 528.9 | 758.4 | 840.9 | 950 | 1,017 | 1,167 |
| Reference price 2 | 6.100 | 5.900 | 3.670 | 6.100 | 6.490 | 9.130 |
| Nbr of stocks (in thousands) | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 | 122,611 |
| Announcement Date | 3/16/21 | 3/16/22 | 3/15/23 | 3/7/24 | 3/18/25 | 3/17/26 |
1BRL in Million2BRL
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 163M | |
| 18.83x | 0.23x | 13.05x | 0.42% | 93.23B | |
| 28.91x | 0.23x | 14.54x | 0.92% | 52.68B | |
| 45.92x | 3.24x | 30.05x | 1.35% | 23.59B | |
| 11.71x | 0.21x | 4.94x | 2.57% | 8.34B | |
| 14x | 1.08x | 8.73x | 2.41% | 8.14B | |
| 6.14x | 0.1x | 2.62x | 4.82% | 6.95B | |
| 9.04x | 1.71x | 5.44x | 3.63% | 6.11B | |
| 24.51x | 1.2x | 14.83x | 2.91% | 5.39B | |
| 11.04x | 0.13x | 4.6x | 4.05% | 3.8B | |
| Average | 18.90x | 0.90x | 10.98x | 2.56% | 20.84B | |
| Weighted average by Cap. | 23.27x | 0.66x | 14.18x | 1.19% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PFRM3 Stock
- Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
